Us Hemodialysis Peritoneal Dialysis Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The U.S. hemodialysis and peritoneal dialysis market is the largest national segment of the global dialysis industry, driven by high ESKD prevalence and a well-developed reimbursement infrastructure through Medicare and the Centers for Medicare & Medicaid Services. In 2025, the U.S. market is valued at approximately $17.69 billion, with expectations of continued mid-single-digit growth. North America retains a dominant share of global revenues, supported by established clinical pathways and broad insurance coverage for renal replacement therapy.

• •2025 market size: approximately $17.69 billion.
• •Forecast CAGR: 4.4%, in line with broader global estimates of 3.8%-6.5% through 2031.
• •North America holds the leading regional position within global dialysis product and service revenues.

Rising ESKD prevalence linked to diabetes, hypertension, and an aging population is the underlying clinical driver of demand. The federal Advancing American Kidney Health initiative set a goal that 80% of new ESKD patients begin on home dialysis or receive a transplant by 2025, redirecting provider investment toward home-based modalities. Reimbursement reform under CMS's ESRD Treatment Choices Model further accelerates the shift to peritoneal dialysis and home hemodialysis.

• •Growing ESKD patient population and improved survival on dialysis sustain long-term demand.
• •U.S. federal policy actively promotes home dialysis and transplantation over in-center hemodialysis.
• •CMS payment models provide financial incentives for providers to expand home dialysis programs.

The market is commonly segmented by treatment type into hemodialysis (the larger share) and peritoneal dialysis, and further by product category into dialyzers, machines, concentrates, catheters, and PD solutions. Within North America, the United States accounts for the bulk of regional value, while Canada contributes a smaller but steadily growing share. Demand for peritoneal dialysis and home hemodialysis is rising faster than for in-center hemodialysis, reflecting both policy goals and patient preference.

• •Hemodialysis retains the larger revenue share, with peritoneal dialysis growing fastest.
• •Product segmentation includes dialyzers, machines, concentrates, catheters, and PD solutions.
• •Home-based modalities (PD and home HD) are expanding more rapidly than in-center care.

What are the recent trends and outlook?

Investment in home dialysis technology is accelerating, with manufacturers introducing more compact, user-friendly peritoneal cyclers and portable home hemodialysis machines intended to improve patient adherence and clinical outcomes. Public policy, payer reform, and patient preference all point toward continued migration out of in-center care over the next decade. As a result, peritoneal dialysis and home hemodialysis product lines are expected to outpace overall market growth through the late 2020s.

• •Next-generation PD cyclers and catheters are improving ease of use and adoption.
• •Home hemodialysis equipment is being redesigned for smaller footprint and simpler patient operation.
• •Modality mix is expected to shift further toward home therapies through 2031.